Embolic protection device and method of use

Abstract
A medical device for embolic protection within a patient's body vessel is provided. The device includes inner and outer tubular members each having proximal and distal ends and a lumen formed through the proximal and distal ends. A flexible everting filter portion includes a body having a first end attached to the distal end of the inner tubular member and a second end attached to the distal end of the outer tubular member. The inner and outer tubular members are movable relative to one another to position the filter portion within the body vessel. The filter portion is movable from a collapsed, everted delivery and removal configuration to an expanded, generally non-everted deployed configuration. The filter portion expands radially outward to engage the filter body with the body vessel. The filter portion allows the passage of blood cells and prevents the passage of emboli or thrombi through the body vessel.
Description
BACKGROUND OF THE INVENTION

1. Field of Invention


The present invention relates to medical devices. More particularly, the invention relates to a medical device for embolic protection.


2. Background


With the continuing advance of medical techniques, interventional procedures are more commonly being used to actively treat stenosis, occlusions, lesions, or other defects within a patient's blood vessels. Often the treated regions are in the coronary, carotid, renal, peripheral, cerebral and other blood vessels. For example, atherectomy or thrombectomy devices can be used to remove atheroma or thrombus. Another procedure for treating an occluded or stenosed blood vessel is angioplasty. During angioplasty, an inflatable balloon is introduced into the occluded region. The balloon is inflated, pushing against the plaque or other material of the stenosed region and increasing the intralumenal diameter of the vessel. As the balloon presses against the material, portions of the material may inadvertently break free from the plaque deposit. These emboli may flow downstream where they may block more distal and smaller blood vessel restricting blood flow to a vital organ, such as the brain. Consequences of embolization include stroke, diminished renal function, and impairment of peripheral circulation possibly leading to pain and amputation.


To prevent the risk of damage from emboli, various filtering devices have been proposed. Such devices typically have elements that form legs or a mesh that would capture embolic material, but allow blood cells to flow between the elements. Capturing the emboli in the filter device prevents the material from being lodged downstream in a smaller blood vessel. The filter may then be removed along with the embolic material after the procedure has been performed and the risk from emboli has decreased.


Many challenges exist with filtering devices. Often it is desirable to deploy filter devices, from the proximal side of a stenosis. Therefore, the profile of the filtering device should be significantly smaller than the opening in the stenosed vessel. If the profile of the filtering device is not significantly smaller than the opening, there is an increased risk of dislodging emboli during insertion of the device. Further, if the filter portion is not held against the inside of the vessel wall, there is a risk that embolic material may pass between the filter and the vessel wall. In addition, if the filtering device becomes filled with particles blood flow through the filtering device may be compromised.


In view of the above, it is apparent that there exists a need for an improved medical device for embolic protection.


BRIEF SUMMARY OF THE INVENTION

The present invention provides an improved medical device for embolic protection and an improved method of embolic protection during a medical procedure, the medical device being applicable to blood vessel, renal, and other applications similar in nature.


In one embodiment, the medical device includes outer and inner catheters and a flexible filter portion attached to both the outer and inner catheters. The outer catheter includes a proximal end and a distal end. An outer lumen is formed through the proximal and distal ends of the outer catheter, defining a proximal opening at the proximal end and a distal opening at the distal end. The inner catheter is movable within the outer catheter and includes a proximal end and a distal end. An inner lumen is formed through the proximal and distal ends of the inner catheter, defining a proximal opening at the proximal end and a distal opening at the distal end.


In this embodiment, the flexible filter portion includes a body extending from a first end to a second end. The first end of the filter portion is attached to the distal end of the inner catheter and the second end of the filter portion is attached to the distal end of the outer catheter. The outer and inner catheters are movable relative to one another to move the filter portion between a collapsed state for delivery and removal of the device and an expanded state for engaging the filter body with a body vessel wall. The distal end of the inner catheter is arranged proximal to the distal end of the outer catheter such that the filter body is everted and defines an everted distal cavity within the distal end of the outer catheter in the collapsed state. The distal end of the inner catheter is movable distal to the distal end of the outer catheter such that the filter body is generally non-everted and defines a cylindrical body extending distally from the distal end of the outer catheter in the expanded state. In both the collapsed and expanded states, the distal ends of the outer catheter and the inner catheter are longitudinally separated by approximately the length of the filter body.


In another embodiment, the medical device includes an elongate outer tubular member and an elongate inner tubular member movable within the outer tubular member. Each of the outer and inner tubular members have a proximal end and a distal end and a lumen formed through the proximal and distal ends defining a proximal opening at the proximal end and a distal opening at the distal end. The medical device further includes a flexible everting filter portion including a body extending from a first end to a second end. The first end is attached to the distal end of the inner tubular member and the second end is attached to the distal end of the outer tubular member. The filter portion is movable between a collapsed delivery and removal configuration and an expanded deployed configuration. The inner and outer tubular members are movable relative to one another to extend the filter portion from the outer tubular member. The filter portion is biased to expand radially outward to engage the filter body with an enclosing body vessel wall in the expanded configuration.


The present invention also includes an improved method of embolic protection during a medical procedure in a patient's body vessel. The method comprises inserting a medical device into an operative position within the body vessel. The medical device includes an outer tubular member and an inner tubular member movable within the outer tubular member. Each of the outer and inner tubular members has a proximal end and a distal end. A lumen is formed through the proximal and distal ends of each of the outer and inner tubular members, defining a proximal opening at the proximal end and a distal opening at the distal end.


In this embodiment, the medical device further includes a flexible filter portion having a body extending from a first end to a second end. The first end of the filter portion is attached to the distal end of the inner tubular member and the second end of the filter portion is attached to the distal end of the outer tubular member. The filter portion is compressed in an everted state within the distal end of the outer tubular member, defining a collapsed configuration during insertion of the medical device.


The method of embolic protection further includes deploying the filter portion within the body vessel to an expanded configuration in which the filter portion extends from the outer tubular member and is biased to expand radially outward to engage the filter body with an enclosing body vessel wall. After the filter portion is deployed within the body vessel, a medical procedure is performed upstream of the filter portion. This includes inserting an elongate medical instrument through the lumen of the inner tubular member into the body vessel adjacent a treatment site and performing the medical procedure. After the medical procedure has been performed, the elongate medical instrument is removed from within the inner tubular member and the body vessel. The inner and outer tubular members are movable relative to one another to position the filter portion back into the collapsed state and the medical device is removed from within the body vessel.


Further objects, features, and advantages of the present invention will become apparent from consideration of the following description and the appended claims when taken in connection with the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1
a is a side cross-sectional view of an embolic protection device in accordance with an embodiment of the present invention, in an everted state for delivery or removal of the device within a patient's body vessel;



FIG. 1
b is a side cross-sectional view of the embolic protection device of FIG. 1a, in a partially everted state;



FIG. 1
c is a side cross-sectional view of the embolic protection device of FIG. 1a, in a generally non-everted state;



FIG. 2 is a cutaway perspective view of an embolic protection device deployed within an aorta in accordance with an embodiment of the present invention;



FIG. 3 is a cutaway perspective view of an embolic protection device deployed within an abdominal aorta in the general vicinity of the renal arteries in accordance with an embodiment of the present invention;



FIG. 4 is a cross-sectional view taken along line 4-4 of FIG. 2;



FIG. 5 is a cross-sectional view taken along line 5-5 of FIG. 3; and



FIG. 6 is a flow chart illustrating a method of embolic protection during a medical procedure in a patient's body vessel.





DETAILED DESCRIPTION OF THE INVENTION

The following provides a detailed description of currently preferred embodiments of the present invention. The description is not intended to limit the invention in any manner, but rather serves to enable those skilled in the art to make and use the invention.


Referring now to FIGS. 1a-c, an embolic protection device embodying the principles of the present invention is denoted by reference numeral 10. The device 10 includes an outer catheter 12, an inner catheter 20, and a flexible filter portion 28. The term catheter as used herein refers to any catheter, cannula, tube, sheath, or the like which is inserted into a patient's vascular system for delivery or withdrawal of fluids and/or introduction of catheters and the like. As illustrated in FIGS. 1a-c, the outer catheter 12 has a proximal end 14 and a distal end 16 and a lumen 18 formed through the proximal and distal ends 14, 16, defining a proximal opening 15 at the proximal end 14 and a distal opening 17 at the distal end 16. The inner catheter 20 has a proximal end 22 and a distal end 24 and a lumen 26 formed through the proximal and distal ends 24, 26, defining a proximal opening 23 at the proximal end 22 and a distal opening 25 at the distal end 24.


In this embodiment, the filter portion 28 includes a flexible filter body 30 movable from an everted state to a generally non-everted state. As shown in FIGS. 1a-c, the filter body 30 extends from a first end 32 attached to the distal end 24 of the inner catheter 20 to a second end 34 attached to the distal end 16 of the outer catheter 12. In a preferred embodiment, the filter portion 28 is compressed within the distal end 16 of the outer catheter 12, defining the everted state. Preferably, as the filter portion 28 moves to the generally non-everted state, i.e., extends distally from the distal end 16 of the outer catheter 12, the filter portion 28 radially expands to engage the filter body 30 with an enclosing body vessel wall. This is discussed in more detail below with reference to FIGS. 2 and 3 as the expanded, generally non-everted deployed state is best illustrated in FIGS. 2 and 3.



FIG. 1
a illustrates an everted state for insertion and removal of the device 10 within a patient's body vessel. In the everted state of FIG. 1a, the inner catheter 20 is proximally disposed within the lumen 18 of the outer catheter 12, the distal end 24 of the inner catheter 20 being arranged proximal to the distal end 16 of the outer catheter 12. In the everted state, the filter body 30 is everted, i.e., rolled inwardly and proximally, through the distal opening 17 of the outer catheter 12 and through a distal portion of the lumen 18 of the outer catheter 12. The inner wall 13 of the outer catheter 12 compresses the everted filter portion 28, defining a collapsed, everted state. Thus, the filter body 30 extends proximally from the second end 34 attached to the distal end 16 of the outer catheter 12 to the first end 32 attached to the distal end 24 of the inner catheter 20, defining an everted cavity or concave region 31 within the distal end 16 of the outer catheter 12.


In this embodiment, the filter body 30 includes an interior surface 36 and an exterior surface 38. In the everted state, the interior surface 36 faces the inner wall 13 of the outer catheter 12 and the exterior surface 38 defines the everted cavity 31 in fluid communication with the lumen 26 of the inner catheter 20. As illustrated in FIG. 1a, the length of the everted cavity 31 is greatest in the everted state, i.e., the filter portion 28 has the greatest degree of eversion in the everted state.


The everting nature of the filter portion 28 may be further understood with reference to a common article of clothing, a sock. A sock may be removed, allowed to hang toe downward, a hand inserted within the interior, the distal toe region pinched with fingers from within, and the pinched region pulled upward, forming an everted toe region which is pulled inside out to form an exterior distal cavity or dimple near the closed end of the sock. The open end of the sock has a proximal opening bounded by a proximal mouth region. The degree of eversion of the sock may be increased by moving the pinched region upward or the open end downward, increasing the amount of material within the distal exterior cavity. The terms filter sock or roll sock may be used interchangeably with filter portion 28 in describing and claiming the present invention.


In this embodiment, the outer and inner catheters 12, 20 are movable relative to one another to move the filter portion 28 to a generally non-everted state. For example, the outer catheter 12 may be moved proximally relative to the inner catheter 20 to unroll the filter portion 28 from the everted state. In another example, the inner catheter 20 may be moved distally relative to the outer catheter 12 to unroll the filter portion 28 from the everted state, or both the outer and inner catheters 12, 20 may be moved proximally and distally, respectively, to unroll the filter portion 28 from the everted state.



FIG. 1
b illustrates a partially everted state in which at least one of the outer and inner catheters 12, 20 is moved relative to the other to move the inner catheter 20 distally within the lumen 18 of the outer catheter 12. In a partially everted state, the distal end 24 of the inner catheter 20 remains proximal to the distal end 16 of the outer catheter 12 and the filter body 30 maintains its everted shape. However, the degree of eversion is smaller than in the everted state, i.e., the length of the everted cavity 31 in a partially everted state is shorter than the length of the everted cavity 31 in the everted state of FIG. 1a. Thus, the length of the everted cavity decreases with decreasing eversion.


As illustrated in FIG. 1b, in a partially everted state, a first portion of the interior surface 36 of the filter body 30 faces the inner wall 13 of the outer catheter 12 and a second portion of the interior surface 36 faces a third portion of the interior surface 36. Further, in a partially everted state, a first portion of the exterior surface 38 of the filter body 30 defines the everted cavity 31 and a second portion of the exterior surface 38 of the filter body 30 faces the interior of a body vessel when disposed within a patient's body vessel.



FIG. 1
c illustrates the filter portion 28 in a generally non-everted state in which the inner catheter 20 is extended through the distal opening 17 of the outer catheter 12 to unroll the everted filter portion to a generally non-everted state. FIG. 1c is merely illustrative of the relative positioning of the filter portion 28 in relation to the inner and outer catheters 20, 12 in a generally non-everted state. FIG. 1c does not illustrate the generally non-everted filter portion 28 in the preferred expanded state as later shown and described with reference to FIGS. 2 and 3. In the generally non-everted state of FIG. 1c, the filter body 30 extends distally from the second end 34 attached to the distal end 16 of the outer catheter 12 to the first end 32 attached to the distal end 24 of the inner catheter 20 such that the filter body 30 no longer defines an everted cavity 31. In this embodiment, the filter body 30 extends from the second end 34 and curves inward and proximally toward the first end 32, defining a proximally facing concave surface 42 adjacent the attachment point of the first end 32 to the distal end 24 of the inner catheter 20.


Further illustrated in FIG. 1c, in the generally non-everted state, the interior surface 36 of the filter body 30 defines the interior 29 of the filter body 30. In the generally non-everted state, the interior 29 of the filter body 30 is in fluid communication with the lumen 18 of the outer catheter 12 such that the inner catheter 20 passes though the lumen 18 and the distal opening 17 of the outer catheter 12 and through the interior 29 of the filter body 30. The interior surface 36 thus faces the outer wall 21 of the inner catheter 20 and the exterior surface 38 faces the interior of a body vessel when disposed within a patient's body vessel.


The term “generally non-everted” includes the embodiment of FIG. 1c, wherein the filter body 30 no longer defines an everted cavity 31, but wherein a very small portion of the filter body 30 curves inward and proximally, thus defining the proximally facing concave surface 42. The term “generally non-everted” further includes embodiments such as those illustrated in FIGS. 2 and 3, wherein the filter body 30 does define an everted cavity 31, but wherein the everted cavity is substantially smaller than in the everted state of FIG. 1a and the partially everted state of FIG. 1b, such that the filter body 30 is capable of engaging the body vessel wall and performing its intended function, i.e., preventing downstream flow of emboli or thrombi.


In both the everted and non-everted states of FIGS. 1a and 1c, respectively, the distal ends 16, 24 of respective outer and inner catheters 12, 20 are longitudinally separated by a distance 40 which is approximately the length of the filter body 30. The term “approximately the length of the filter body 30” includes a length equal to the length of the filter body 30 less the very small portion of the filter body 30 which either curves inward and proximally near the first end 32 in the non-everted state (i.e., the proximally facing concave surface 42), or curves inward and proximally near the second end 34 in the everted state (FIG. 1a), give or take the difference in length between the filter body 30 in the collapsed state and the filter body 30 in the expanded state. The distance 40 is thus substantially equal to the length of the everted cavity 31 in the everted state.



FIGS. 2 and 4 show an embolic protection device 10 deployed within a patient's aorta 50 in an expanded, generally non-everted deployed state. In this embodiment, the device 10 is inserted in the collapsed, everted state into the aorta 50 in a retrograde fashion. Preferably, this is done through a peripheral arterial access, such as the femoral artery or subclavian artery, using the Seldinger technique or an arterial cutdown. Accordingly, the outer and inner catheters 12, 20 should have a length sufficient to reach from the arterial access point where the device 10 is inserted to the ascending aorta 56 of the patient. For femoral artery deployment, the outer and inner catheters 12, 20 preferably have a length of about 80-120 cm. The inner catheter 20 is preferably longer than the outer catheter 12 by about at least the length of the filter body 30 in the expanded, generally non-everted state such that the proximal ends 14, 22 of both the outer and inner catheters 12, 20, respectively, are accessible from outside the patient's body to control the movement of the outer and inner catheters 12, 20 relative to one another.


In this embodiment, the position of the device 10 may be monitored using fluoroscopy or ultrasound. Appropriate markers, which may include radiopaque markers and/or sonoreflective markers, may be located on the distal ends 16, 24 of the outer and/or inner catheters 12, 20, and/or the filter portion 28 to enhance imaging and to show the position of the device 10 and the deployment state of the filter portion 28. As shown in FIG. 2, the device 10 is positioned within the descending thoracic aorta 54 proximal to a treatment site near the ascending aorta 56. The outer and inner catheters 12, 20 are movable relative to one another to deploy the filter portion 28 to the expanded, generally non-everted state proximal to the treatment site.


In this embodiment, the filter portion 28 is made of an expandable fine mesh material configured to expand to conform to the diameter of the body vessel. Thus, the diameter of the filter portion 28 in the collapsed, everted state is smaller than the diameter of the filter portion 28 in the expanded, generally non-everted state. The mesh filter portion 28 has a cylindrical geometry in the generally non-everted deployed state which includes an open region at the second end 34 and an enclosed region extending from the second end to the first end 32. In the generally non-everted state, the second end 34 is attached to and extends distally from the distal end 16 of the outer catheter 12, thus defining the open region through which the lumen 18 of the outer catheter 12 fluidly communicates with the interior 29 of the filter portion 28. The filter body 30 extends distally from the second end 34 and curves inwardly and proximally toward the first end 32 attached to the distal end 24 of the inner catheter 20, thus defining the proximally facing concave surface 42. The proximally facing concave surface 42 extends from the portion of the filter body 30 which engages the body vessel wall 51 toward the first end 32 attached to the distal end 24 of the inner catheter 20.


In this embodiment, the filter portion 28 may be attached to the inner and outer catheters 20, 12 by any suitable means in the art. For example, the filter portion 28 may be thermally or adhesively bonded to each of the inner and outer catheters 20, 12, on either the inside or outside of the inner and outer catheters 20, 12. Alternatively, the filter portion 28 may be an integral part of one of the inner and outer catheters 20, 12. For example, one of the inner and outer catheters 20, 12 may be formed from an inner layer of braided wire and an outer layer of polymer. The filter portion 28 may be an extension of the braided wire of one of the inner and outer catheters 20, 12 without the surrounding outer polymer layer. The filter portion 28 may be attached to the other one of the inner and outer catheters 20, 12 via thermal or adhesive bonding, or any other suitable means.


In this embodiment, the mesh material making up the filter portion 28 includes a plurality of elements 44, such as wires, fibers, or strands, which can be used to form the mesh material through a variety of methods, for example, braiding, knitting, weaving, helically winding, and counterwinding. The mesh material can be fused at some or all of the element 44 intersection points. The mesh material can also be electrospun, and formed of sheet or film having holes formed by laser drilling, punching dissolving components selectively, and the like. The elements 44 can be formed of material such as wire, which can be metallic or polymeric wire. The wire may be substantially circular in cross section or may have any number of square, rectangular or irregular cross sectional profiles.


The mesh material is formed such that the diameter of the filter portion 28 can expand or contract while maintaining its generally cylindrical geometry. To facilitate deployment of the device 10, the filter portion 28 is preferably biased to expand. However, when contracted, the cylindrical geometry is everted and provides a smaller profile during insertion and removal of the device 10 and facilitates delivery of the device 10 through the stenosis. The elements 44 may be comprised of any suitable material such as a superelastic material, stainless steel wire, cobalt-chromium-nickel-molybdenum-iron alloy, or cobalt-chrome alloy. Alternatively, the elements 44 may be formed of a synthetic material. For example, Nylon, Dacron, Thorolon, or ePTFE may be used. The fine mesh material of the filter portion 28 may be a woven or knitted fabric such as Dacron polyester or nylon mesh, or other textile fabrics, or it may be a nonwoven fabric, such as spun bonded polyolefin or ePTFE or other nonwoven materials. The fine mesh material of the filter portion 28 may be woven, knitted or otherwise formed from monofilament or multifilament fibers. The mesh material of the filter portion 28 may also be a fine wire mesh or a combination of wire and textile fibers. Depending on the application, the mesh material may include multiple layers or a composite mesh of elements 44, such as a nano-fiber mesh. Alternatively, the fine mesh material may be an open cell foam material.


Further, it is understood that the elements 44 may be formed of any other suitable material that will result in a flexible everting geometry, such as shape memory alloys. The mesh material is preferably self-expanding. The self-expanding mesh material can be formed totally or in part from self-expanding Nitinol, Elgiloy, titanium, or stainless steel wires and the like, and combinations thereof. The self-expanding mesh material can also be formed of engineering polymers, for example, liquid crystal polymer, PEEK, polyamide, polyester, and the like. A preferred mesh material is formed of Nitinol wires, which can be heat set to the desired expanded shape. The mesh material can preferably be heat set to a desired bias shape using any suitable method known in the art. In another example, the mesh material is highly elastic, and preformed by mechanical overstress to the desired expanded shape. The mesh material may be made partly or totally radiopaque by means of plating, core wires, tracer wires, or fillers that have good x-ray absorption characteristics compared to the human body.


In this embodiment, the mesh material includes openings 46 between the elements 44 that are large enough to allow the flow of blood therethrough, but small enough to prevent the passage of emboli or thrombi therethrough. Accordingly, the elements 44 may be configured such that the openings 46 between the elements 44 are between about 1-200 micrometers. The preferred opening or pore size of the mesh filter body 30 depends on the specific application and whether to prevent the passage of macroemboli only or macroemboli and microemboli. In most cases the pore size of the mesh filter body 30 will preferably be in the range of about 1-200 micrometers. For preventing the passage of macroemboli only, the pore size of the mesh filter body 30 will preferably be in the range of about 50-200 micrometers. For preventing the passage of macroemboli and microemboli, the pore size of the mesh filter body 30 will preferably be in the range of about 1-100 micrometers. In other applications, such as for treating thomboembolic disease, a larger pore size, e.g. up to 1000 micrometers or larger, may be useful. A filter body 30 having openings 46 of these sizes will allow blood cells to pass through the openings 46 while larger emboli or thrombi are restrained by the elements 44 from traveling downstream within the body vessel. In some embodiments, a combination of filter materials having different pore sizes may be used.


Alternatively or additionally, the mesh material of the filter portion 28 may be made of or coated with an adherent material or substance to capture or hold embolic debris or thrombi which comes into contact with the filter portion 28. Suitable adherent materials include, but are not limited to, known biocompatible adhesives and bioadhesive materials or substances, which are hemocompatible and non-thrombogenic. In a preferred embodiment, only the upstream side of the elements 44 of the proximally facing concave surface 42 of the filter portion 28 is coated with the adherent material to positively capture the embolic debris which comes in contact with the proximally facing concave surface 42 of the filter portion 28.


Referring to FIGS. 2 and 4, the filter portion 28 is positioned proximal to a medical surgical or treatment site, wherein the filter portion 28 is configured to move to the expanded, generally non-everted state to engage the body vessel wall. In this embodiment, the expanded filter portion 28 includes a cylindrical geometry adapted to span the diameter of the patient's body vessel, such that the filter portion 28 is radially biased against the wall of the vessel. An elongate medical instrument 60, such as a third catheter, is insertable through the lumen 26 of the inner catheter 20 in order to perform a medical procedure upstream of the filter portion 28. If any embolic materials are dislodged during the medical procedure, the enclosed region of the filter portion 28 prevents the embolic materials from traveling downstream through the body vessel and into surrounding vessel branches. The openings 46 defined by the elements 44 making up the porous mesh material of the filter portion 28 allow blood cells to flow downstream through the body vessel and into surrounding vessel branches. Thus, in the embodiments of FIGS. 2 and 3, the filter portion 28 permits blood flow to continue to the left and right renal 57, 58 and the abdominal aorta, yet prevents emboli or thrombi from entering into the left and right renal 57, 58 and the abdominal aorta.


After the medical procedure has been performed, the elongate medical instrument 60 is withdrawn from within the inner catheter 20 and the patient's body vessel. In this embodiment, the outer and inner catheters 12, 20 are movable relative to one another to roll or evert the filter portion 28 back into its collapsed, everted state for removal of the medical device 10. Preferably, as the filter portion 28 is manipulated into its collapsed, everted state, the everted cavity 31 swallows or captures the restrained emboli or thrombi within the outer catheter 12 for removal from the patient's body vessel. The medical device 10 is then withdrawn from within the patient's body vessel.


Referring to FIG. 3, a device 10 in accordance with an embodiment of the present invention is positioned within the patient's aorta directly at the branch site of the left and right renal 57, 58. In this embodiment, a plurality of markers 70a and 70b is integrated into the filter portion 28 to help the physician monitor the deployment of the filter portion 28. The markers are preferably tungsten loaded nylon. In this embodiment, the markers 70a are preferably positioned in an axial direction to mark the renal branch site and the markers 70b are preferably positioned perpendicular to the axial direction to follow the deployment of the expandable filter portion 28.



FIG. 5 shows a cross-sectional view of the device 10 in FIG. 3 taken along line 5-5, along the proximally facing concave surface 42 of the filter portion 28. As illustrated, in the region defined by the proximally facing concave surface 42, the elements 44 engage the body vessel wall 51 and traverse the lumen of the body vessel towards the distal end 24 of the inner catheter 20, thus defining the enclosed region of the filter portion 28.


Referring to FIG. 6, a method of embolic protection during a medical procedure is provided. The method includes inserting (80) a medical device 10, as discussed in the forgoing paragraphs, into an operative position within a body vessel of a patient. During insertion, the filter portion 28 is in the collapsed, everted configuration.


The filter portion 28 is deployed (82) to the expanded, generally non-everted configuration within the body vessel. Deploying the filter portion 28 includes moving the outer and inner catheters 12, 20 relative to one another such that the distal end 24 of the inner catheter 20 and the first end 32 of the filter portion 28 extend distally from the distal end 16 of the outer catheter 12.


An elongate medical instrument 60, such as a catheter, is inserted (84) within the lumen 26 of the inner catheter 20 via the proximal opening 23 of the inner catheter 20. The medical instrument 60 passes through the distal opening 25 of the inner catheter 20 and the first end 32 of the filter portion 28 to perform the medical procedure within the body vessel of the patient upstream of the filter portion 28. The filter portion 28 permits blood flow to surrounding vessels while preventing any dislodged emboli or thrombi from flowing downstream and entering surrounding vessels.


After the medical procedure is performed (86), the medical instrument 60 is removed (88) from within the inner catheter 20 and the body vessel of the patient. Thereafter, the medical device 10 is removed (90) from within the body vessel of the patient. Removing the medical device 10 includes moving the outer and inner catheters 12, 20 relative to one another to evert the filter portion 28 back into its collapsed, everted state, wherein the distal end 24 of the inner catheter 20 and the first end 32 of the filter portion 28 are arranged proximally within the outer catheter 12. Preferably, as the filter portion 28 is everted back into its collapsed everted state, emboli or thrombi are collected within the everted cavity 31 at the distal end 16 of the outer catheter 12 and removed with the medical device 10.


As a person skilled in the art will readily appreciate, the above description is meant as an illustration of the implementation of the principles of this invention. This description is not intended to limit the scope or application of this invention in that the invention is susceptible to modification variation and change, without departing from the spirit of this invention, as defined in the following claims.

Claims
  • 1. A medical device for embolic protection within a patient's body vessel, the medical device having a first lumen and a second lumen, the medical device comprising: an outer catheter having a proximal end and a distal end, the outer catheter having an outer lumen formed through the proximal and distal ends defining a proximal opening at the proximal end and a distal opening at the distal end of the outer catheter;an inner catheter movable within the outer catheter and having a proximal end and a distal end, the inner catheter having an inner lumen formed through the proximal and distal ends defining a proximal opening at the proximal end and a distal opening at the distal end of the inner catheter; anda flexible filter portion having a body extending from a first end to a second end, the first end being attached to the distal end of the inner catheter and the second end being attached to the distal end of the outer catheter, the outer catheter and the inner catheter movable relative to one another to move the filter portion between a collapsed state for delivery and removal of the device and an expanded state for engaging the filter body with a body vessel wall, the distal end of the inner catheter being arranged proximal to the distal end of the outer catheter such that the filter body is everted and defines a distal cavity within the distal end of the outer catheter in the collapsed state, the distal end of the inner catheter being movable distal to the distal end of the outer catheter such that the filter body is generally non-everted and defines a cylindrical body extending distally from the distal end of the outer catheter in the expanded state and enclosing a region configured to allow blood flow into surrounding vessel branches prevent emboli or thrombi from entering into the surrounding vessel branches, the distal ends of the outer catheter and the inner catheter being longitudinally separated by approximately the length of the filter body in the collapsed state and in the expanded state.
  • 2. The medical device of claim 1, wherein the filter body includes an opening at the first end and a proximally facing concave surface adjacent the second end in the collapsed state, the proximally facing concave surface defining the distal cavity and the opening providing fluid communication between the inner catheter lumen and the distal cavity.
  • 3. The medical device of claim 1, wherein the filter body includes an opening at the second end and a proximally facing concave surface adjacent the first end in the expanded state, the proximally facing concave surface defining an interior of the filter portion and the opening providing fluid communication between the outer catheter lumen and the interior of the filter portion.
  • 4. The medical device of claim 3, wherein the inner catheter is disposed within the interior of the filter portion in the expanded state.
  • 5. The medical device of claim 1, further comprising an elongate instrument movable longitudinally within the inner catheter lumen relative to the inner catheter and extendible through the proximal and distal openings of the inner catheter.
  • 6. The medical device of claim 1, wherein the filter portion includes a plurality of elements defining a plurality of openings sized to allow blood cells to pass through the filter openings and prevent the passage of emboli.
  • 7. The medical device of claim 1, wherein the filter portion includes a porous expandable mesh structure.
  • 8. The medical device of claim 7, wherein the mesh structure is constructed from a material selected from the group consisting of polyester, nylon, Dacron, thorolon, ePTFE, stainless steel, nickel-titanium alloys, and cobalt-base alloys.
  • 9. The medical device of claim 1, wherein the filter portion includes at least one radiopaque marker to assist in monitoring deployment of the filter portion.
  • 10. The medical device of claim 1, wherein the device is configured to be positioned within the body vessel such that the filter portion in the expanded state is longitudinally disposed within the first lumen and transversely disposed relative to the second lumen, wherein the filter portion allows blood cells to pass through the first lumen and into the second lumen and prevents emboli from entering the second lumen.
  • 11. A medical device for capturing emboli in a patient's body vessel, the medical device having a first lumen and a second lumen, the medical device comprising: an elongate outer tubular member and an elongate inner tubular member movable within the outer tubular member, each of the outer and inner tubular members having a proximal end and a distal end and a lumen formed through the proximal and distal ends defining a proximal opening at the proximal end and a distal opening at the distal end; and
  • 12. The medical device of claim 11, wherein the first end of the filter portion attached to the distal end of the inner tubular member is arranged proximal to the second end of the filter portion attached to the distal end of the outer tubular member defining an everted distal cavity in the collapsed configuration.
  • 13. The medical device of claim 11, wherein the first end of the filter portion attached to the distal end of the inner tubular member is arranged distal to the second end of the filter portion attached to the distal end of the outer tubular member defining a cylindrical distal extension of the outer tubular member in the expanded configuration.
  • 14. The medical device of claim 11, wherein the filter portion includes an interior surface and an exterior surface, the interior surface facing an inner wall of the outer tubular member and the exterior surface defining an everted distal cavity within the distal end of the outer tubular member in the collapsed configuration, the interior surface defining an interior of the filter portion through which the inner tubular member extends and the exterior surface being configured to engage the body vessel in the expanded configuration.
  • 15. The medical device of claim 11, wherein the filter portion includes a plurality of elements defining a plurality of openings sized to allow blood cells to pass through the filter openings and prevent the passage of emboli.
  • 16. The medical device of claim 11, wherein the filter portion includes a porous expandable mesh structure constructed from a material selected from the group consisting of polyester, nylon, Dacron, thorolon, ePTFE, stainless steel, nickel-titanium alloys, and cobalt-base alloys.
  • 17. The medical device of claim 11, further comprising an elongate instrument movable longitudinally within the inner tubular member lumen relative to the inner tubular member and extendible through the proximal and distal openings of the inner tubular member.
US Referenced Citations (861)
Number Name Date Kind
3108593 Glassman Oct 1963 A
3334629 Cohn Aug 1967 A
3472230 Fogarty Oct 1969 A
3547103 Cook Dec 1970 A
3635223 Klieman Jan 1972 A
3923065 Nozick et al. Dec 1975 A
3952747 Kimmell, Jr. Apr 1976 A
3978863 Fettel et al. Sep 1976 A
3996938 Clark, III Dec 1976 A
4425908 Simon Jan 1984 A
4456000 Schjeldahl et al. Jun 1984 A
4494531 Gianturco Jan 1985 A
4548206 Osborne Oct 1985 A
4561439 Bishop et al. Dec 1985 A
4562039 Koehler Dec 1985 A
4604094 Shook Aug 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4643184 Mobin-Uddin Feb 1987 A
4646736 Auth Mar 1987 A
4650472 Bates Mar 1987 A
4665906 Jervis May 1987 A
4669464 Sulepov Jun 1987 A
4688553 Metals Aug 1987 A
4723549 Wholey et al. Feb 1988 A
4727873 Mobin-Uddin Mar 1988 A
4732152 Wallstén et al. Mar 1988 A
4817600 Herms et al. Apr 1989 A
4824435 Giesy et al. Apr 1989 A
4832055 Palestrant May 1989 A
4846794 Hertzer Jul 1989 A
4848343 Wallstén et al. Jul 1989 A
4873978 Ginsburg Oct 1989 A
4943297 Saveliev et al. Jul 1990 A
4957501 Lahille et al. Sep 1990 A
4990156 Lefebvre Feb 1991 A
4998916 Hammerslag et al. Mar 1991 A
5053008 Bajaj Oct 1991 A
5059205 El-Nounou et al. Oct 1991 A
5069226 Yamauchi et al. Dec 1991 A
5078726 Kreamer Jan 1992 A
5100423 Fearnot Mar 1992 A
5108418 Lefebvre Apr 1992 A
5108419 Reger et al. Apr 1992 A
5112347 Taheri May 1992 A
5129890 Bates et al. Jul 1992 A
5133733 Rasmussen et al. Jul 1992 A
5147379 Sabbaghian et al. Sep 1992 A
5152777 Goldberg Oct 1992 A
5160342 Reger Nov 1992 A
5163927 Woker et al. Nov 1992 A
5203772 Hammerslag et al. Apr 1993 A
5234458 Metais Aug 1993 A
5242462 El-Nounou Sep 1993 A
5243996 Hall Sep 1993 A
5251640 Osborne Oct 1993 A
5263964 Purdy Nov 1993 A
5300086 Gory et al. Apr 1994 A
5324304 Rasmussen Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5344427 Cottenceau et al. Sep 1994 A
5350397 Palermo et al. Sep 1994 A
5350398 Pavcnik et al. Sep 1994 A
5364345 Lowery et al. Nov 1994 A
5370657 Irie Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5383887 Nadal Jan 1995 A
5413586 Dibie et al. May 1995 A
5415630 Gory et al. May 1995 A
5417708 Hall et al. May 1995 A
5451233 Yock Sep 1995 A
5458573 Summers Oct 1995 A
5522881 Lentz Jun 1996 A
5527338 Purdy Jun 1996 A
5531788 Dibie et al. Jul 1996 A
5549551 Peacock et al. Aug 1996 A
5549626 Miller et al. Aug 1996 A
5556414 Turi Sep 1996 A
5562698 Parker Oct 1996 A
5571135 Fraser et al. Nov 1996 A
5591195 Taheri et al. Jan 1997 A
5601595 Smith Feb 1997 A
5624461 Mariant Apr 1997 A
5626605 Irie et al. May 1997 A
5630797 Diedrich et al. May 1997 A
5634942 Chevillon et al. Jun 1997 A
5649953 Lefebvre Jul 1997 A
5662703 Yurek et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5681347 Cathcart et al. Oct 1997 A
5690642 Osborne et al. Nov 1997 A
5690667 Gia Nov 1997 A
5693067 Purdy Dec 1997 A
5693087 Parodi Dec 1997 A
5695518 Laerum Dec 1997 A
5695519 Summers et al. Dec 1997 A
5700253 Parker Dec 1997 A
5709704 Nott et al. Jan 1998 A
5713853 Clark et al. Feb 1998 A
5720764 Naderlinger Feb 1998 A
5725550 Nadal Mar 1998 A
5738667 Solar Apr 1998 A
5746767 Smith May 1998 A
5755772 Evans et al. May 1998 A
5755790 Chevillon et al. May 1998 A
5766203 Imran et al. Jun 1998 A
5769816 Barbut et al. Jun 1998 A
5769871 Mers et al. Jun 1998 A
5795322 Boudewijn Aug 1998 A
5800457 Gelbfish et al. Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814027 Hassett et al. Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5820592 Hammerslag Oct 1998 A
5827324 Cassell et al. Oct 1998 A
5830230 Berryman et al. Nov 1998 A
5836968 Simon et al. Nov 1998 A
5836969 Kim et al. Nov 1998 A
5846260 Maahs Dec 1998 A
5853420 Chevillon et al. Dec 1998 A
5876367 Kaganov et al. Mar 1999 A
5893869 Barnhart et al. Apr 1999 A
5895391 Farnholtz Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5895410 Forber et al. Apr 1999 A
5908435 Samuels Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911702 Romley et al. Jun 1999 A
5911704 Humes Jun 1999 A
5911717 Jacobsen et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5919224 Thompson et al. Jul 1999 A
5925062 Purdy Jul 1999 A
5925063 Khosravi Jul 1999 A
5928260 Chine et al. Jul 1999 A
5928261 Ruiz Jul 1999 A
5938683 Lefebvre Aug 1999 A
5941896 Kerr Aug 1999 A
5944728 Bates Aug 1999 A
5947985 Imran Sep 1999 A
5947995 Samuels Sep 1999 A
5948017 Taheri Sep 1999 A
5951567 Javier, Jr. et al. Sep 1999 A
5954741 Fox Sep 1999 A
5954742 Osypka Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5968057 Taheri Oct 1999 A
5968071 Chevillon et al. Oct 1999 A
5972019 Engelson et al. Oct 1999 A
5976162 Doan et al. Nov 1999 A
5976172 Homsma et al. Nov 1999 A
5980555 Barbut et al. Nov 1999 A
5984947 Smith Nov 1999 A
5984965 Knapp et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6007558 Ravenscloth et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013093 Nott et al. Jan 2000 A
6015424 Rosenbluth et al. Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6036717 Mers Kelly et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6051014 Jang Apr 2000 A
6051015 Maahs Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059745 Gelbfish May 2000 A
6059813 Vrba et al. May 2000 A
6059814 Ladd May 2000 A
6063113 Kavteladze et al. May 2000 A
6066158 Engelson et al. May 2000 A
6068645 Tu May 2000 A
6074357 Kaganov et al. Jun 2000 A
6077274 Ouchi et al. Jun 2000 A
6080178 Meglin Jun 2000 A
6083239 Addis Jul 2000 A
6086577 Ken et al. Jul 2000 A
6086605 Barbut et al. Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096053 Bates Aug 2000 A
6096070 Ragheb et al. Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6106497 Wang Aug 2000 A
6126672 Berryman et al. Oct 2000 A
6126673 Kim et al. Oct 2000 A
6129739 Khosravi Oct 2000 A
6136016 Barbut et al. Oct 2000 A
6146396 Konya et al. Nov 2000 A
6146404 Kim et al. Nov 2000 A
6152931 Nadal et al. Nov 2000 A
6152946 Broome et al. Nov 2000 A
6152947 Ambrisco et al. Nov 2000 A
6156061 Wallace et al. Dec 2000 A
6156062 McGuinness Dec 2000 A
6159230 Samuels Dec 2000 A
6165179 Cathcart et al. Dec 2000 A
6165198 McGurk et al. Dec 2000 A
6165199 Barbut Dec 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita et al. Jan 2001 B1
6168603 Leslie et al. Jan 2001 B1
6168610 Marin et al. Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6171328 Addis Jan 2001 B1
6174318 Bates et al. Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179860 Fulton, III et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6187025 Machek Feb 2001 B1
6193739 Chevillon et al. Feb 2001 B1
6203561 Ramee et al. Mar 2001 B1
6206931 Cook et al. Mar 2001 B1
6214025 Thistle et al. Apr 2001 B1
6214026 Lepak et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6224620 Maahs May 2001 B1
6231588 Zadno-Azizi May 2001 B1
6231589 Wessman et al. May 2001 B1
6235044 Root et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6238412 Dubrul et al. May 2001 B1
6241746 Bosma et al. Jun 2001 B1
6245012 Kleshinski Jun 2001 B1
6245087 Addis Jun 2001 B1
6245088 Lowery Jun 2001 B1
6245089 Daniel et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6254550 McNamara et al. Jul 2001 B1
6254633 Pinchuk et al. Jul 2001 B1
6258026 Ravenscroft et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6264672 Fisher Jul 2001 B1
6267776 O'Connell Jul 2001 B1
6267777 Bosma et al. Jul 2001 B1
6273900 Nott et al. Aug 2001 B1
6273901 Whitcher et al. Aug 2001 B1
6277125 Barry et al. Aug 2001 B1
6277126 Barry et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6277139 Levinson et al. Aug 2001 B1
6280451 Bates et al. Aug 2001 B1
6287321 Jang Sep 2001 B1
6290710 Cryer et al. Sep 2001 B1
6299604 Ragheb et al. Oct 2001 B1
6306163 Fitz Oct 2001 B1
6309399 Barbut et al. Oct 2001 B1
6312444 Barbut Nov 2001 B1
6319268 Ambrisco et al. Nov 2001 B1
6325815 Kusleika et al. Dec 2001 B1
6325816 Fulton, III et al. Dec 2001 B1
6328755 Marshall Dec 2001 B1
6331183 Suon Dec 2001 B1
6331184 Abrams Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6336934 Gilson et al. Jan 2002 B1
6338739 Datta et al. Jan 2002 B1
6340364 Kanesaka Jan 2002 B2
6342062 Suon et al. Jan 2002 B1
6342063 DeVries et al. Jan 2002 B1
6344048 Chin et al. Feb 2002 B1
6344049 Levinson et al. Feb 2002 B1
6346116 Brooks et al. Feb 2002 B1
6348041 Klint Feb 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350271 Kurz et al. Feb 2002 B1
6355051 Sisskind et al. Mar 2002 B1
6358228 Tubman et al. Mar 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6361546 Khosravi Mar 2002 B1
6361547 Hieshima Mar 2002 B1
6364895 Greenhalgh Apr 2002 B1
6364896 Addis Apr 2002 B1
6368338 Konya et al. Apr 2002 B1
6371961 Osborne et al. Apr 2002 B1
6371969 Tsugita et al. Apr 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371971 Tsugita et al. Apr 2002 B1
6375670 Greenhalgh Apr 2002 B1
6379374 Hieshima et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6383146 Klint May 2002 B1
6383171 Gifford et al. May 2002 B1
6383174 Eder May 2002 B1
6383193 Cathcart et al. May 2002 B1
6383196 Leslie et al. May 2002 B1
6383205 Samson et al. May 2002 B1
6383206 Gillick et al. May 2002 B1
6391044 Yadav et al. May 2002 B1
6391045 Kim et al. May 2002 B1
6391052 Buirge et al. May 2002 B2
6395014 Macoviak et al. May 2002 B1
6402771 Palmer et al. Jun 2002 B1
6402772 Amplatz et al. Jun 2002 B1
6409742 Fulton, III et al. Jun 2002 B1
6413235 Parodi Jul 2002 B1
6416530 DeVries et al. Jul 2002 B2
6419686 McLeod et al. Jul 2002 B1
6423052 Escano Jul 2002 B1
6423086 Barbut et al. Jul 2002 B1
6425909 Dieck et al. Jul 2002 B1
6428557 Hilaire Aug 2002 B1
6428558 Jones et al. Aug 2002 B1
6428559 Johnson Aug 2002 B1
6432122 Gilson et al. Aug 2002 B1
6436112 Wensel et al. Aug 2002 B2
6436120 Meglin Aug 2002 B1
6436121 Blom Aug 2002 B1
6443926 Kletschka Sep 2002 B1
6443971 Boylan et al. Sep 2002 B1
6443972 Bosma et al. Sep 2002 B1
6443979 Stalker et al. Sep 2002 B1
6447530 Ostrovsky et al. Sep 2002 B1
6447531 Amplatz Sep 2002 B1
6454775 Demarais et al. Sep 2002 B1
6458139 Palmer et al. Oct 2002 B1
6458145 Ravenscroft et al. Oct 2002 B1
6461370 Gray et al. Oct 2002 B1
6468290 Weldon et al. Oct 2002 B1
6468291 Bates et al. Oct 2002 B2
6482222 Bruckheimer et al. Nov 2002 B1
6485456 Kletschka Nov 2002 B1
6485500 Kokish et al. Nov 2002 B1
6485501 Green Nov 2002 B1
6485502 Don Michael et al. Nov 2002 B2
6491712 O'Connor Dec 2002 B1
6494895 Addis Dec 2002 B2
6497709 Heath Dec 2002 B1
6499487 McKenzie et al. Dec 2002 B1
6500166 Zadno Azizi et al. Dec 2002 B1
6500191 Addis Dec 2002 B2
6502606 Klint Jan 2003 B2
6506203 Boyle et al. Jan 2003 B1
6506205 Goldberg et al. Jan 2003 B2
6508826 Murphy et al. Jan 2003 B2
6511492 Rosenbluth et al. Jan 2003 B1
6511496 Huter et al. Jan 2003 B1
6511497 Braun et al. Jan 2003 B1
6511503 Burkett et al. Jan 2003 B1
6514273 Voss et al. Feb 2003 B1
6517559 O'Connell Feb 2003 B1
6520978 Blackledge et al. Feb 2003 B1
6520983 Colgan et al. Feb 2003 B1
6527746 Oslund et al. Mar 2003 B1
6527791 Fisher Mar 2003 B2
6527962 Nadal Mar 2003 B1
6530935 Wensel et al. Mar 2003 B2
6530939 Hopkins et al. Mar 2003 B1
6530940 Fisher Mar 2003 B2
6533770 Lepulu et al. Mar 2003 B1
6533800 Barbut Mar 2003 B1
6537293 Berryman et al. Mar 2003 B1
6537294 Boyle et al. Mar 2003 B1
6537296 Levinson et al. Mar 2003 B2
6537297 Tsugita et al. Mar 2003 B2
6540722 Boyle et al. Apr 2003 B1
6540767 Walak et al. Apr 2003 B1
6540768 Diaz et al. Apr 2003 B1
6544221 Kokish et al. Apr 2003 B1
6544276 Azizi Apr 2003 B1
6544278 Vrba et al. Apr 2003 B1
6544279 Hopkins et al. Apr 2003 B1
6544280 Daniel et al. Apr 2003 B1
6547759 Fisher Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6551341 Boylan et al. Apr 2003 B2
6551342 Shen et al. Apr 2003 B1
6554849 Jones et al. Apr 2003 B1
6558404 Tsukernik May 2003 B2
6558405 McInnes May 2003 B1
6558406 Okada May 2003 B2
6562058 Seguin et al. May 2003 B2
6565591 Brady et al. May 2003 B2
6569147 Evans et al. May 2003 B1
6569183 Kim et al. May 2003 B1
6569184 Huter May 2003 B2
6575995 Huter et al. Jun 2003 B1
6575996 Denison et al. Jun 2003 B1
6575997 Palmer et al. Jun 2003 B1
6579303 Amplatz Jun 2003 B2
6582396 Parodi Jun 2003 B1
6582447 Patel et al. Jun 2003 B1
6582448 Boyle et al. Jun 2003 B1
6589227 Klint Jul 2003 B2
6589230 Gia et al. Jul 2003 B2
6589263 Hopkins et al. Jul 2003 B1
6589264 Barbut et al. Jul 2003 B1
6589265 Palmer et al. Jul 2003 B1
6589266 Whitcher et al. Jul 2003 B2
6592546 Barbut et al. Jul 2003 B1
6592606 Huter et al. Jul 2003 B2
6592616 Stack et al. Jul 2003 B1
6595983 Voda Jul 2003 B2
6596011 Johnson et al. Jul 2003 B2
6599275 Fischer, Jr. Jul 2003 B1
6599307 Huter et al. Jul 2003 B1
6599308 Amplatz Jul 2003 B2
6602271 Adams et al. Aug 2003 B2
6602273 Marshall Aug 2003 B2
6602280 Chobotov Aug 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6607506 Kletschka Aug 2003 B2
6610077 Hancock et al. Aug 2003 B1
6611720 Hata et al. Aug 2003 B2
6613074 Mitelberg et al. Sep 2003 B1
6616679 Khosravi et al. Sep 2003 B1
6616680 Thielen Sep 2003 B1
6616681 Hanson et al. Sep 2003 B2
6616682 Joergensen et al. Sep 2003 B2
6620148 Tsugita Sep 2003 B1
6620182 Khosravi et al. Sep 2003 B1
6623450 Dutta Sep 2003 B1
6623506 McGuckin, Jr. et al. Sep 2003 B2
6629953 Boyd Oct 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6635069 Teoh et al. Oct 2003 B1
6635070 Leeflang et al. Oct 2003 B2
6638293 Makower et al. Oct 2003 B1
6638294 Palmer Oct 2003 B1
6638372 Abrams et al. Oct 2003 B1
6641590 Palmer et al. Nov 2003 B1
6641605 Stergiopulos Nov 2003 B1
6645160 Heesch Nov 2003 B1
6645220 Huter et al. Nov 2003 B1
6645221 Richter Nov 2003 B1
6645222 Parodi et al. Nov 2003 B1
6645223 Boyle et al. Nov 2003 B2
6645224 Gilson et al. Nov 2003 B2
6652554 Wholey et al. Nov 2003 B1
6652557 MacDonald Nov 2003 B1
6652558 Patel et al. Nov 2003 B2
6656201 Ferrera et al. Dec 2003 B2
6656202 Papp et al. Dec 2003 B2
6656203 Roth et al. Dec 2003 B2
6656204 Ambrisco et al. Dec 2003 B2
6656351 Boyle Dec 2003 B2
6660021 Palmer et al. Dec 2003 B1
6663613 Evans et al. Dec 2003 B1
6663650 Sepetka et al. Dec 2003 B2
6663651 Krolik et al. Dec 2003 B2
6663652 Daniel et al. Dec 2003 B2
6676682 Tsugita et al. Jan 2004 B1
6679902 Boyle et al. Jan 2004 B1
6689144 Gerberding Feb 2004 B2
6695813 Boyle et al. Feb 2004 B1
6695865 Boyle et al. Feb 2004 B2
6702834 Boylan et al. Mar 2004 B1
6709450 Kang et al. Mar 2004 B2
6712835 Mazzocchi et al. Mar 2004 B2
6716207 Farnholtz Apr 2004 B2
6716231 Rafiee et al. Apr 2004 B1
6726701 Gilson et al. Apr 2004 B2
6730064 Ragheb et al. May 2004 B2
6755855 Yurek et al. Jun 2004 B2
6755856 Fierens et al. Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6761727 Ladd Jul 2004 B1
6773446 Dwyer et al. Aug 2004 B1
6773448 Kusleika et al. Aug 2004 B2
6774278 Ragheb et al. Aug 2004 B1
6780175 Sachdeva et al. Aug 2004 B1
6793667 Hebert et al. Sep 2004 B2
6793668 Fisher Sep 2004 B1
6833002 Stack et al. Dec 2004 B2
6855154 Abdel-Gawwad Feb 2005 B2
6866677 Douk et al. Mar 2005 B2
6866680 Yassour et al. Mar 2005 B2
6872211 White et al. Mar 2005 B2
6878153 Linder et al. Apr 2005 B2
6896691 Boylan et al. May 2005 B2
6929709 Smith Aug 2005 B2
6932831 Forber Aug 2005 B2
6939361 Kleshinski Sep 2005 B1
6942682 Vrba et al. Sep 2005 B2
6955685 Escamilla et al. Oct 2005 B2
6964670 Shah et al. Nov 2005 B1
6964674 Matsuura et al. Nov 2005 B1
6969396 Krolik et al. Nov 2005 B2
6974469 Broome et al. Dec 2005 B2
6974473 Barclay et al. Dec 2005 B2
6986784 Weiser et al. Jan 2006 B1
6991641 Diaz et al. Jan 2006 B2
7128073 Van der Burg et al. Oct 2006 B1
7166120 Kusleika Jan 2007 B2
7174636 Lowe Feb 2007 B2
7189249 Hart et al. Mar 2007 B2
7204847 Gambale Apr 2007 B1
7255687 Huang et al. Aug 2007 B2
7285130 Austin Oct 2007 B2
7306619 Palmer Dec 2007 B1
7371248 Dapolito et al. May 2008 B2
7393358 Malewicz Jul 2008 B2
7604649 McGuckin et al. Oct 2009 B2
7666216 Hogendijk et al. Feb 2010 B2
7731722 Lavelle et al. Jun 2010 B2
7766934 Pal et al. Aug 2010 B2
20010000799 Wessman et al. May 2001 A1
20010001817 Humes May 2001 A1
20010005789 Root et al. Jun 2001 A1
20010007947 Kanesaka Jul 2001 A1
20010011181 DiMatteo Aug 2001 A1
20010011182 Dubrul et al. Aug 2001 A1
20010012951 Bates et al. Aug 2001 A1
20010016755 Addis Aug 2001 A1
20010020175 Yassour et al. Sep 2001 A1
20010023358 Tsukernik Sep 2001 A1
20010025187 Okada Sep 2001 A1
20010031980 Wensel et al. Oct 2001 A1
20010031981 Evans et al. Oct 2001 A1
20010031982 Peterson et al. Oct 2001 A1
20010039431 DeVries et al. Nov 2001 A1
20010039432 Whitcher et al. Nov 2001 A1
20010041908 Levinson et al. Nov 2001 A1
20010041909 Tsugita et al. Nov 2001 A1
20010041928 Pavcnik et al. Nov 2001 A1
20010044632 Daniel et al. Nov 2001 A1
20010044634 Don Michael et al. Nov 2001 A1
20010053921 Jang Dec 2001 A1
20020002383 Sepetka et al. Jan 2002 A1
20020002384 Gilson et al. Jan 2002 A1
20020004667 Adams et al. Jan 2002 A1
20020016564 Courtney et al. Feb 2002 A1
20020016609 Wensel et al. Feb 2002 A1
20020022858 Demond et al. Feb 2002 A1
20020022859 Hogendijk Feb 2002 A1
20020026211 Khosravi et al. Feb 2002 A1
20020026212 Wholey et al. Feb 2002 A1
20020026213 Gilson et al. Feb 2002 A1
20020032460 Kusleika et al. Mar 2002 A1
20020032461 Marshall Mar 2002 A1
20020042626 Hanson et al. Apr 2002 A1
20020042627 Brady et al. Apr 2002 A1
20020045915 Balceta et al. Apr 2002 A1
20020045916 Gray et al. Apr 2002 A1
20020045918 Suon et al. Apr 2002 A1
20020049452 Kurz et al. Apr 2002 A1
20020049468 Streeter et al. Apr 2002 A1
20020052627 Boylan et al. May 2002 A1
20020058904 Boock et al. May 2002 A1
20020058911 Gilson et al. May 2002 A1
20020058963 Vale et al. May 2002 A1
20020058964 Addis May 2002 A1
20020062133 Gilson et al. May 2002 A1
20020062134 Barbut et al. May 2002 A1
20020062135 Mazzocchi et al. May 2002 A1
20020065507 Zadno-Azizi May 2002 A1
20020068954 Foster Jun 2002 A1
20020068955 Khosravi Jun 2002 A1
20020072764 Sepetka et al. Jun 2002 A1
20020072765 Mazzocchi et al. Jun 2002 A1
20020077596 McKenzie et al. Jun 2002 A1
20020082558 Samson et al. Jun 2002 A1
20020082639 Broome et al. Jun 2002 A1
20020087187 Mazzocchi et al. Jul 2002 A1
20020090389 Humes et al. Jul 2002 A1
20020091407 Zadno-Azizi et al. Jul 2002 A1
20020091408 Sutton et al. Jul 2002 A1
20020091409 Sutton et al. Jul 2002 A1
20020095170 Krolik et al. Jul 2002 A1
20020095171 Belef Jul 2002 A1
20020095172 Mazzocchi et al. Jul 2002 A1
20020095173 Mazzocchi et al. Jul 2002 A1
20020095174 Tsugita et al. Jul 2002 A1
20020099405 Yurek et al. Jul 2002 A1
20020099407 Becker et al. Jul 2002 A1
20020099435 Stinson Jul 2002 A1
20020103501 Diaz et al. Aug 2002 A1
20020107541 Vale et al. Aug 2002 A1
20020111647 Khairkhahan et al. Aug 2002 A1
20020111648 Kusleika et al. Aug 2002 A1
20020111649 Russo et al. Aug 2002 A1
20020116024 Goldberg et al. Aug 2002 A1
20020120226 Beck Aug 2002 A1
20020120286 DoBrava et al. Aug 2002 A1
20020120287 Huter Aug 2002 A1
20020123720 Kusleika et al. Sep 2002 A1
20020123755 Lowe et al. Sep 2002 A1
20020123759 Amplatz Sep 2002 A1
20020123766 Seguin et al. Sep 2002 A1
20020128679 Turovskiy et al. Sep 2002 A1
20020128680 Pavlovic Sep 2002 A1
20020128681 Broome et al. Sep 2002 A1
20020133191 Khosravi et al. Sep 2002 A1
20020133192 Kusleika et al. Sep 2002 A1
20020138094 Borillo et al. Sep 2002 A1
20020138095 Mazzocchi et al. Sep 2002 A1
20020138096 Hieshima Sep 2002 A1
20020138097 Ostrovsky et al. Sep 2002 A1
20020143360 Douk et al. Oct 2002 A1
20020143361 Douk et al. Oct 2002 A1
20020143362 Macoviak et al. Oct 2002 A1
20020151927 Douk et al. Oct 2002 A1
20020151928 Leslie et al. Oct 2002 A1
20020156520 Boylan et al. Oct 2002 A1
20020161389 Boyle et al. Oct 2002 A1
20020161390 Mouw Oct 2002 A1
20020161391 Murphy et al. Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161393 Demond et al. Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020161395 Douk et al. Oct 2002 A1
20020161396 Jang et al. Oct 2002 A1
20020165557 McAlister Nov 2002 A1
20020165573 Barbut Nov 2002 A1
20020165576 Boyle et al. Nov 2002 A1
20020165598 Wahr et al. Nov 2002 A1
20020169472 Douk et al. Nov 2002 A1
20020169474 Kusleika et al. Nov 2002 A1
20020173815 Hogendijk et al. Nov 2002 A1
20020173819 Leeflang et al. Nov 2002 A1
20020177872 Papp et al. Nov 2002 A1
20020177899 Eum et al. Nov 2002 A1
20020183781 Casey et al. Dec 2002 A1
20020183782 Tsugita et al. Dec 2002 A1
20020183783 Shadduck Dec 2002 A1
20020188313 Johnson et al. Dec 2002 A1
20020188314 Anderson et al. Dec 2002 A1
20020193824 Boylan et al. Dec 2002 A1
20020193825 McGuckin et al. Dec 2002 A1
20020193826 McGuckin et al. Dec 2002 A1
20020193827 McGuckin et al. Dec 2002 A1
20020193828 Griffin et al. Dec 2002 A1
20020198561 Amplatz Dec 2002 A1
20030004536 Boylan et al. Jan 2003 A1
20030004537 Boyle et al. Jan 2003 A1
20030004538 Secrest et al. Jan 2003 A1
20030004539 Linder et al. Jan 2003 A1
20030004540 Linder et al. Jan 2003 A1
20030004541 Linder et al. Jan 2003 A1
20030004542 Wensel et al. Jan 2003 A1
20030009146 Muni et al. Jan 2003 A1
20030009189 Gilson et al. Jan 2003 A1
20030009190 Kletschka et al. Jan 2003 A1
20030009191 Wensel et al. Jan 2003 A1
20030014072 Wensel et al. Jan 2003 A1
20030018354 Roth et al. Jan 2003 A1
20030018355 Goto et al. Jan 2003 A1
20030023263 Krolik et al. Jan 2003 A1
20030023264 Dieck et al. Jan 2003 A1
20030023265 Forber Jan 2003 A1
20030032976 Boucck Feb 2003 A1
20030032977 Brady Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030045897 Huter et al. Mar 2003 A1
20030045898 Harrison et al. Mar 2003 A1
20030050662 Don Michael Mar 2003 A1
20030055452 Joergensen et al. Mar 2003 A1
20030055480 Fischell et al. Mar 2003 A1
20030060843 Boucher Mar 2003 A1
20030060844 Borillo et al. Mar 2003 A1
20030065354 Boyle et al. Apr 2003 A1
20030065355 Weber Apr 2003 A1
20030065356 Tsugita et al. Apr 2003 A1
20030069596 Eskuri Apr 2003 A1
20030073979 Naimark et al. Apr 2003 A1
20030074019 Gray et al. Apr 2003 A1
20030074054 Duerig et al. Apr 2003 A1
20030078614 Salahieh et al. Apr 2003 A1
20030083608 Evans et al. May 2003 A1
20030083692 Vrba et al. May 2003 A1
20030083693 Daniel et al. May 2003 A1
20030088211 Anderson et al. May 2003 A1
20030088266 Bowlin May 2003 A1
20030093110 Vale May 2003 A1
20030093112 Addis May 2003 A1
20030097094 Ouriel et al. May 2003 A1
20030097145 Goldberg et al. May 2003 A1
20030100917 Boyle et al. May 2003 A1
20030100918 Duane May 2003 A1
20030100919 Hopkins et al. May 2003 A1
20030105472 McAlister Jun 2003 A1
20030105484 Boyle et al. Jun 2003 A1
20030105486 Murphy et al. Jun 2003 A1
20030109824 Anderson et al. Jun 2003 A1
20030109897 Walak et al. Jun 2003 A1
20030109916 Don Michael Jun 2003 A1
20030114879 Euteneuer et al. Jun 2003 A1
20030114880 Hansen et al. Jun 2003 A1
20030120303 Boyle et al. Jun 2003 A1
20030120304 Kaganov et al. Jun 2003 A1
20030125764 Brady et al. Jul 2003 A1
20030125765 Blackledge et al. Jul 2003 A1
20030130680 Russell Jul 2003 A1
20030130681 Ungs Jul 2003 A1
20030130682 Broome et al. Jul 2003 A1
20030130684 Brady et al. Jul 2003 A1
20030130685 Daniel et al. Jul 2003 A1
20030130686 Daniel et al. Jul 2003 A1
20030130687 Daniel et al. Jul 2003 A1
20030130688 Daniel et al. Jul 2003 A1
20030135232 Douk et al. Jul 2003 A1
20030135233 Bates et al. Jul 2003 A1
20030139764 Levinson et al. Jul 2003 A1
20030139765 Patel et al. Jul 2003 A1
20030144685 Boyle et al. Jul 2003 A1
20030144686 Martinez et al. Jul 2003 A1
20030144687 Brady et al. Jul 2003 A1
20030144688 Brady et al. Jul 2003 A1
20030144689 Brady et al. Jul 2003 A1
20030150821 Bates et al. Aug 2003 A1
20030153935 Mialhe Aug 2003 A1
20030153942 Wang et al. Aug 2003 A1
20030153943 Michael et al. Aug 2003 A1
20030153944 Phung et al. Aug 2003 A1
20030153945 Patel et al. Aug 2003 A1
20030158518 Schonholz et al. Aug 2003 A1
20030158574 Esch et al. Aug 2003 A1
20030158575 Boylan et al. Aug 2003 A1
20030163158 White Aug 2003 A1
20030163159 Patel et al. Aug 2003 A1
20030167068 Amplatz Sep 2003 A1
20030167069 Gonzales et al. Sep 2003 A1
20030171769 Barbut Sep 2003 A1
20030171770 Kusleika et al. Sep 2003 A1
20030171771 Anderson et al. Sep 2003 A1
20030171772 Amplatz Sep 2003 A1
20030171800 Bicek et al. Sep 2003 A1
20030171803 Shimon Sep 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030176885 Broome et al. Sep 2003 A1
20030176886 Wholey et al. Sep 2003 A1
20030176887 Petersen Sep 2003 A1
20030176888 O'Connell Sep 2003 A1
20030176889 Boyle et al. Sep 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030181943 Daniel et al. Sep 2003 A1
20030187474 Keegan et al. Oct 2003 A1
20030187475 Tsugita et al. Oct 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030191492 Gellman et al. Oct 2003 A1
20030191493 Epstein et al. Oct 2003 A1
20030195554 Shen et al. Oct 2003 A1
20030195555 Khairkhahan et al. Oct 2003 A1
20030195556 Stack et al. Oct 2003 A1
20030199819 Beck Oct 2003 A1
20030199917 Knudson et al. Oct 2003 A1
20030199918 Patel et al. Oct 2003 A1
20030199919 Palmer et al. Oct 2003 A1
20030199920 Boylan et al. Oct 2003 A1
20030199921 Palmer et al. Oct 2003 A1
20030204168 Bosma et al. Oct 2003 A1
20030204202 Palmer et al. Oct 2003 A1
20030204203 Khairkhahan et al. Oct 2003 A1
20030208222 Zadno-Azizi Nov 2003 A1
20030208224 Broome Nov 2003 A1
20030208225 Goll et al. Nov 2003 A1
20030208226 Bruckheimer et al. Nov 2003 A1
20030208227 Thomas Nov 2003 A1
20030208228 Gilson et al. Nov 2003 A1
20030208229 Kletschka Nov 2003 A1
20030208253 Beyer et al. Nov 2003 A1
20030212428 Richter Nov 2003 A1
20030212429 Keegan et al. Nov 2003 A1
20030212431 Brady et al. Nov 2003 A1
20030212432 Khairkhahan et al. Nov 2003 A1
20030212433 Ambrisco et al. Nov 2003 A1
20030212434 Thielen Nov 2003 A1
20030216774 Larson Nov 2003 A1
20030220665 Eskuri et al. Nov 2003 A1
20030220667 Van der Burg et al. Nov 2003 A1
20030225418 Esksuri et al. Dec 2003 A1
20030225435 Hunter et al. Dec 2003 A1
20030229374 Brady et al. Dec 2003 A1
20030233117 Adams et al. Dec 2003 A1
20040006364 Ladd Jan 2004 A1
20040006365 Brady et al. Jan 2004 A1
20040006370 Tsugita Jan 2004 A1
20040015152 Day Jan 2004 A1
20040039412 Isshiki et al. Feb 2004 A1
20040049226 Keegan et al. Mar 2004 A1
20040054394 Lee Mar 2004 A1
20040054395 Lee et al. Mar 2004 A1
20040059372 Tsugita Mar 2004 A1
20040064067 Ward Apr 2004 A1
20040064179 Linder et al. Apr 2004 A1
20040068271 McAlister Apr 2004 A1
20040078044 Kear Apr 2004 A1
20040082962 Demarais et al. Apr 2004 A1
20040088038 Dehnad et al. May 2004 A1
20040093009 Denison et al. May 2004 A1
20040093012 Cully et al. May 2004 A1
20040093016 Root et al. May 2004 A1
20040093059 Lee et al. May 2004 A1
20040098022 Barone May 2004 A1
20040098026 Joergensen et al. May 2004 A1
20040098033 Leeflang et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040102719 Keith et al. May 2004 A1
20040106944 Daniel et al. Jun 2004 A1
20040116831 Vrba Jun 2004 A1
20040133232 Rosenbluth et al. Jul 2004 A1
20040138696 Drasler et al. Jul 2004 A1
20040153118 Clubb et al. Aug 2004 A1
20040158278 Becker et al. Aug 2004 A1
20040162576 Barbut et al. Aug 2004 A1
20040164030 Lowe et al. Aug 2004 A1
20040167567 Cano et al. Aug 2004 A1
20040176794 Khosravi Sep 2004 A1
20040176833 Pavcnik et al. Sep 2004 A1
20040199203 Oslund et al. Oct 2004 A1
20040204737 Boismier et al. Oct 2004 A1
20040215322 Kerr Oct 2004 A1
20040225321 Krolik et al. Nov 2004 A1
20040236369 Dubrul Nov 2004 A1
20050004663 Llanos et al. Jan 2005 A1
20050021125 Stack et al. Jan 2005 A1
20050027345 Horan et al. Feb 2005 A1
20050038468 Panetta et al. Feb 2005 A1
20050038503 Greenhaigh Feb 2005 A1
20050043743 Dennis Feb 2005 A1
20050043756 Lavelle et al. Feb 2005 A1
20050043780 Gifford et al. Feb 2005 A1
20050049668 Jones et al. Mar 2005 A1
20050126979 Lowe et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050149110 Wholey et al. Jul 2005 A1
20050165480 Jordan et al. Jul 2005 A1
20050177186 Cully et al. Aug 2005 A1
20050177246 Datta et al. Aug 2005 A1
20050197688 Theron et al. Sep 2005 A1
20050209634 Brady et al. Sep 2005 A1
20050216053 Douk et al. Sep 2005 A1
20050217767 Barvosa-Carter et al. Oct 2005 A1
20050228474 Laguna Oct 2005 A1
20060009798 Callister et al. Jan 2006 A1
20060009799 Kleshinski et al. Jan 2006 A1
20060020334 Lashinski et al. Jan 2006 A1
20060030923 Gunderson Feb 2006 A1
20060074474 Theron Apr 2006 A1
20060100544 Ayala et al. May 2006 A1
20060100545 Ayala et al. May 2006 A1
20060161241 Barbut et al. Jul 2006 A1
20060184194 Pal et al. Aug 2006 A1
20060200221 Malewicz Sep 2006 A1
20060229660 Pal et al. Oct 2006 A1
20060264707 Kinney Nov 2006 A1
20060287668 Fawzi et al. Dec 2006 A1
20070038241 Pal Feb 2007 A1
20070100372 Schaeffer May 2007 A1
20070112374 Paul, Jr. et al. May 2007 A1
20070129752 Webler et al. Jun 2007 A1
20070149996 Coughlin Jun 2007 A1
20070167974 Cully et al. Jul 2007 A1
20070185521 Bui et al. Aug 2007 A1
20070250108 Boyle et al. Oct 2007 A1
20070288054 Tanaka et al. Dec 2007 A1
20080015518 Huang et al. Jan 2008 A1
20080027481 Gilson et al. Jan 2008 A1
20080103522 Steingisser et al. May 2008 A1
20080154236 Elkins et al. Jun 2008 A1
20080167629 Dann et al. Jul 2008 A1
20080255587 Cully et al. Oct 2008 A1
20080255606 Mitra et al. Oct 2008 A1
20080262337 Falwell et al. Oct 2008 A1
20080275569 Lesh Nov 2008 A1
Foreign Referenced Citations (13)
Number Date Country
3429850 Feb 1986 DE
1127556 Aug 2001 EP
1310219 May 2003 EP
1516601 Mar 2005 EP
1557137 Jul 2005 EP
WO9203097 Mar 1992 WO
WO 9610591 Apr 1996 WO
WO 9916382 Apr 1999 WO
WO 9923976 May 1999 WO
WO 9944510 Sep 1999 WO
WO 0182831 Nov 2001 WO
WO 03077799 Sep 2003 WO
WO 2006138391 Dec 2006 WO
Non-Patent Literature Citations (8)
Entry
Rubicon Embolic Filter, The Next Generation of EM, Rubicon Medical, www.rubiconmed.com.
Heeschen et al., Nature Medicine 7 (2001), No. 7, pp. 833-839.
Johnson et al., Circulation Research 94 (2004), No. 2, pp. 262-268.
International Search Report and Written Opinion for PCT/US2007/020300.
Brochure, “Shuttle Select™ System for Carotid Artery Access,” (2004), pp. 1-3.
Brochure, “Slip-Cath® Angiographic Selective Catheters,” (2004), pp. 1-6.
Finol, E.A. et al., “Performance Assessment of Embolic Protection Filters for Carotid Artery Stenting,” Modelling in Medicine and Biology IV, (2005), vol. 8, pp. 133.
Grummon, David S. et al., Appl. Phys. Lett., 82, 2727 (2003), pp. 2727.
Related Publications (1)
Number Date Country
20100168785 A1 Jul 2010 US